Clinical Trial

The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to check whether follicular fluid evaluation using a spectrophotometer can differentiate high quality oocytes from low quality oocytes. Oocyte quality will be defined using GDF9, BMP15 and oocyte morphology. The correlation between cortisol levels in women and oocyte quality parameters will be estimated.
Trial Details
NCT Number NCT07329998
Lead Sponsor Hillel Yaffe Medical Center
Conditions Oocyte Quality Assessment Using Spectrophotometer
Enrollment 200 participants
Start Date 2024-09-22
Primary Completion 2025-12-16 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-09